News & Updates

Do GLP1 receptor agonists increase thyroid cancer risk?

20 Apr 2024 by

Use of glucagon-like peptide 1 (GLP1) receptor agonists does not contribute to an elevated risk of thyroid cancer, as shown in a Scandinavian cohort study with a mean follow-up of nearly 4 years.

Do GLP1 receptor agonists increase thyroid cancer risk?

20 Apr 2024

Keeping blood sugar under control reduces CRC risk in people with diabetes

20 Apr 2024

For individuals with diabetes mellitus (DM), optimal glycaemic control may protect against the risk of developing colonic adenoma and colorectal cancer (CRC), as reported in a population-based cohort study.

Keeping blood sugar under control reduces CRC risk in people with diabetes

20 Apr 2024

What are the risk factors for severe infections in hospitalized SLE patients?

19 Apr 2024

Among hospitalized patients with systemic lupus erythematosus (SLE), factors such as low immunoglobulin, anti-dsDNA antibody positivity, and cyclophosphamide use contribute to an increased risk of recurrent severe infections, according to a study.

What are the risk factors for severe infections in hospitalized SLE patients?

19 Apr 2024

Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis

19 Apr 2024

Analysing molecular signatures from active skin lesions aids in the stratification of patients with contact dermatitis (CD) and helps identify those with allergic CD, suggests a study.

Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis

19 Apr 2024

Novel stent works wonders for adults with intracranial aneurysm

19 Apr 2024 by

Application of the modified Alpha stent, an intracranial closed-cell stent with a unique mesh design, delivers satisfactory outcomes in coil embolization of unruptured distal internal carotid artery (ICA) aneurysms, reports a study. Its recent adjustment facilitates a less complicated delivery and deployment.

Novel stent works wonders for adults with intracranial aneurysm

19 Apr 2024

Albuminuria predicts disease progression in patients with CKD and normoalbuminuria

19 Apr 2024

The risk for chronic kidney disease (CKD) progression is higher for people with CKD and normal albuminuria, reveals a study, adding that such risk increases with higher levels of albuminuria.

Albuminuria predicts disease progression in patients with CKD and normoalbuminuria

19 Apr 2024

LDL-C lowering with bempedoic acid reduces cardiovascular events in high-risk population

19 Apr 2024

The use of bempedoic acid helps lower low-density lipoprotein cholesterol (LDL-C) levels and subsequently reduce cardiovascular events in individuals at high cardiovascular risk, according to the CLEAR* Outcomes trial.

LDL-C lowering with bempedoic acid reduces cardiovascular events in high-risk population

19 Apr 2024

Olezarsen reduces triglyceride levels in adults with hypertriglyceridemia

19 Apr 2024 by

Monthly administration of olezarsen 50 or 80 mg significantly reduced triglyceride levels in patients with predominantly moderate hypertriglyceridemia (HTG) and elevated cardiovascular (CV) risk, according to the Bridge-TIMI 73a trial presented at ACC.24.

Olezarsen reduces triglyceride levels in adults with hypertriglyceridemia

19 Apr 2024

Surgery beneficial to select older adults with epilepsy

18 Apr 2024

Epilepsy surgery may hold promise for carefully selected patients past the age of 50 years, according to a study.

Surgery beneficial to select older adults with epilepsy

18 Apr 2024

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

18 Apr 2024

Patients using multiple insulin injections demonstrate no significant difference in changes to A1c, insulin requirements, or weight after a year of treatment with a sodium glucose transporter 2 (SGLT2) inhibitor or glucagon-like peptide 1 (GLP1) receptor agonist, as shown in a study.

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

18 Apr 2024

News & Updates

Filter by Specialty:

Specialty:

Do GLP1 receptor agonists increase thyroid cancer risk?

Do GLP1 receptor agonists increase thyroid cancer risk?

Keeping blood sugar under control reduces CRC risk in people with diabetes

Keeping blood sugar under control reduces CRC risk in people with diabetes

What are the risk factors for severe infections in hospitalized SLE patients?

What are the risk factors for severe infections in hospitalized SLE patients?

Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis

Gene profiling of skin lesions improves diagnosis of allergic contact dermatitis

Novel stent works wonders for adults with intracranial aneurysm

Novel stent works wonders for adults with intracranial aneurysm

Albuminuria predicts disease progression in patients with CKD and normoalbuminuria

Albuminuria predicts disease progression in patients with CKD and normoalbuminuria

LDL-C lowering with bempedoic acid reduces cardiovascular events in high-risk population

LDL-C lowering with bempedoic acid reduces cardiovascular events in high-risk population

Olezarsen reduces triglyceride levels in adults with hypertriglyceridemia

Olezarsen reduces triglyceride levels in adults with hypertriglyceridemia

Surgery beneficial to select older adults with epilepsy

Surgery beneficial to select older adults with epilepsy

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?

Is it safe to use GLP1 agonists, SGLT2 inhibitors in patients on multiple insulin injections?